Evidence map›Paper›PMID 28820713›Full record

ArticleThe American journal of tropical medicine and hygiene2017

Quality Testing of Artemisinin-Based Antimalarial Drugs in Myanmar.

Suqin Guo, Myat Phone Kyaw, Lishan He, Myo Min, Xiangxue Ning, Wei Zhang, Baomin Wang, Liwang Cui

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook.International journal for parasitology. Drugs and drug resistance · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Effect of artemisinin and neurectomy of pterygoid canal in ovalbumin-induced allergic rhinitis mouse model.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Suqin GuoCollege of Agronomy and Biotechnology, China Agricultural University, Beijing, China.
Myat Phone KyawMyanmar Medical Association, Yangon, Myanmar.
Lishan HeBreeding Base of Guangxi Key Laboratory of Agri-Environment and Agri-Products Safety, Nanning, Guangxi, China.
Myo MinMyanmar Medical Association, Yangon, Myanmar.
Xiangxue NingCollege of Agronomy and Biotechnology, China Agricultural University, Beijing, China.
Wei ZhangCollege of Agronomy and Biotechnology, China Agricultural University, Beijing, China.
Baomin WangCollege of Agronomy and Biotechnology, China Agricultural University, Beijing, China.
Liwang CuiDepartment of Entomology, Pennsylvania State University, University Park, Pennsylvania.

Funding

Southeast Asia Malaria Research CenterU19AI089672 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI CUI, LIWANG · 2010 to 2023
$28.9M
NIAID NIH HHS U19 AI089672
6 · The paper itself

Abstract

Artemisinin-based combination therapies are the frontline treatment of

Indexed as

Counterfeit DrugsAntimalarialsArtemisininsDrug Therapy, CombinationHumansMyanmarAntimalarialsartemisininArtemisininsCounterfeit Drugs

Identifiers

PMID28820713
PMCPMC5637622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.